Paxman KTP to create new device to prevent chemotherapy side-effect CIPN

Press/Media: Research


The two-year ‘Knowledge Transfer Partnership’ between the University and Paxman will design and develop a medical cooling system for the prevention of Chemotherapy-induced peripheral neuropathy (CIPN), a common, dose-limiting side-effect experienced by 30%-40% of patients receiving chemotherapy for cancer of which no effective prevention and treatment strategies currently exist 

Period15 Dec 2021

Media coverage


Media coverage